NCT02879175

Brief Summary

After endovascular treatment of the intracranial aneurysm, recanalization may occur, with a risk of recurrent subarachnoid haemorrhage or long-term angiographic recurrences of aneurysms. Few data exist on patients' long-term follow-up after subarachnoid haemorrhage caused by ruptured intracranial aneurysms.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
68mo left

Started Sep 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress63%
Sep 2016Jan 2032

First Submitted

Initial submission to the registry

August 22, 2016

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 25, 2016

Completed
14 days until next milestone

Study Start

First participant enrolled

September 8, 2016

Completed
15 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2031

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2032

Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

15 years

First QC Date

August 22, 2016

Last Update Submit

January 16, 2026

Conditions

Intracranial Aneurysms

Outcome Measures

Primary Outcomes (1)

  • early neurological clinical recovery

    modified Rankin scale

    1 year after Subarachnoid Haemorrhage

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients undergoing endovascular treatment for a subarachnoid haemorrhage caused by ruptured intracranial aneurysms.

You may qualify if:

  • \- Patient treated with embolization for SAH due to aneurysmal rupture

You may not qualify if:

  • \- Patient refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Fondation Opthalmologique A de Rothschild

Paris, France, 75019, France

Location

MeSH Terms

Conditions

Intracranial Aneurysm

Condition Hierarchy (Ancestors)

Intracranial Arterial DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesAneurysmVascular DiseasesCardiovascular Diseases

Study Officials

  • Raphaël BLANC

    Fondation ophtalmologique de Rothschild

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 22, 2016

First Posted

August 25, 2016

Study Start

September 8, 2016

Primary Completion (Estimated)

September 1, 2031

Study Completion (Estimated)

January 1, 2032

Last Updated

January 20, 2026

Record last verified: 2026-01

Locations

FR(1)